Peter Doocy

Well, something that gives me hope is Dr. Singh. I mean, listening to her, how articulate she is, and I'm so proud that she's our chief medical officer at Texas Children's Hospital. I mean, what could be better than that, right? I mean, just that was really brilliant. And, by the way, the pediatricians at Texas Children's are an extraordinary group of people.

Well, something that gives me hope is Dr. Singh. I mean, listening to her, how articulate she is, and I'm so proud that she's our chief medical officer at Texas Children's Hospital. I mean, what could be better than that, right? I mean, just that was really brilliant. And, by the way, the pediatricians at Texas Children's are an extraordinary group of people.

I mean, and pediatricians in general in our country. I mean, the commitment, the passion, I mean, it comes through every time you talk to an American pediatrician most times. And so that gives me a lot of hope. Yeah. The other thing that gives me hope is the science itself is extraordinary.

I mean, and pediatricians in general in our country. I mean, the commitment, the passion, I mean, it comes through every time you talk to an American pediatrician most times. And so that gives me a lot of hope. Yeah. The other thing that gives me hope is the science itself is extraordinary.

I mean, and pediatricians in general in our country. I mean, the commitment, the passion, I mean, it comes through every time you talk to an American pediatrician most times. And so that gives me a lot of hope. Yeah. The other thing that gives me hope is the science itself is extraordinary.

I mean, we made a low-cost COVID vaccine that reached 100 million people in India and Indonesia, showing that you can actually bypass big pharma companies to do that. We did that in our labs at Texas Children's. Now we have a new hookworm anemia vaccine that's protecting close to 100%. We're excited about that. Finally, we got the mRNA technology working to a point where...

I mean, we made a low-cost COVID vaccine that reached 100 million people in India and Indonesia, showing that you can actually bypass big pharma companies to do that. We did that in our labs at Texas Children's. Now we have a new hookworm anemia vaccine that's protecting close to 100%. We're excited about that. Finally, we got the mRNA technology working to a point where...

I mean, we made a low-cost COVID vaccine that reached 100 million people in India and Indonesia, showing that you can actually bypass big pharma companies to do that. We did that in our labs at Texas Children's. Now we have a new hookworm anemia vaccine that's protecting close to 100%. We're excited about that. Finally, we got the mRNA technology working to a point where...

and getting reliable results. And now we're looking at cancer vaccines with that technology. So I think I could imagine a whole new generation of cancer vaccines and maybe vaccines for other chronic conditions, including neurodegenerative conditions. That's exciting. The problem that we're going to face is our technology

and getting reliable results. And now we're looking at cancer vaccines with that technology. So I think I could imagine a whole new generation of cancer vaccines and maybe vaccines for other chronic conditions, including neurodegenerative conditions. That's exciting. The problem that we're going to face is our technology

and getting reliable results. And now we're looking at cancer vaccines with that technology. So I think I could imagine a whole new generation of cancer vaccines and maybe vaccines for other chronic conditions, including neurodegenerative conditions. That's exciting. The problem that we're going to face is our technology

has outpaced our ability to do this, has outpaced our political social instruments to get them accepted. And that's going to be the big challenge. And so how we... kind of bring this back and start making that bridge and reaching people to get them to accept all of this exciting developments in biomedical science and to somehow talk about the dangers of what's happening with disinformation.

has outpaced our ability to do this, has outpaced our political social instruments to get them accepted. And that's going to be the big challenge. And so how we... kind of bring this back and start making that bridge and reaching people to get them to accept all of this exciting developments in biomedical science and to somehow talk about the dangers of what's happening with disinformation.

has outpaced our ability to do this, has outpaced our political social instruments to get them accepted. And that's going to be the big challenge. And so how we... kind of bring this back and start making that bridge and reaching people to get them to accept all of this exciting developments in biomedical science and to somehow talk about the dangers of what's happening with disinformation.

I think this is going to be one of our biggest challenges.

I think this is going to be one of our biggest challenges.

I think this is going to be one of our biggest challenges.

Well, there is an accountability mechanism. I mean, some of the worst offenders have now had their board certification revoked and that sort of thing. But it's a slow process. It could be years of litigation and litigation. So it's not easy and it's extremely unpleasant, of course, and you like to hope that it doesn't get to that point.

Well, there is an accountability mechanism. I mean, some of the worst offenders have now had their board certification revoked and that sort of thing. But it's a slow process. It could be years of litigation and litigation. So it's not easy and it's extremely unpleasant, of course, and you like to hope that it doesn't get to that point.

Well, there is an accountability mechanism. I mean, some of the worst offenders have now had their board certification revoked and that sort of thing. But it's a slow process. It could be years of litigation and litigation. So it's not easy and it's extremely unpleasant, of course, and you like to hope that it doesn't get to that point.